Invesco’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.7M | Sell |
400,947
-42,740
| -10% | -$1.35M | ﹤0.01% | 1636 |
|
|
2025
Q1 | $14.7M | Sell |
443,687
-5,493
| -1% | -$182K | ﹤0.01% | 1579 |
|
|
2024
Q4 | $15.5M | Buy |
449,180
+285,156
| +174% | +$9.81M | ﹤0.01% | 1615 |
|
|
2024
Q3 | $6.56M | Buy |
164,024
+13,090
| +9% | +$524K | ﹤0.01% | 2058 |
|
|
2024
Q2 | $4.55M | Buy |
150,934
+17,026
| +13% | +$514K | ﹤0.01% | 2240 |
|
|
2024
Q1 | $4.5M | Buy |
133,908
+19,732
| +17% | +$663K | ﹤0.01% | 2300 |
|
|
2023
Q4 | $3.69M | Sell |
114,176
-12,267
| -10% | -$396K | ﹤0.01% | 2385 |
|
|
2023
Q3 | $4.14M | Sell |
126,443
-20,986
| -14% | -$688K | ﹤0.01% | 2301 |
|
|
2023
Q2 | $5.19M | Sell |
147,429
-806,902
| -85% | -$28.4M | ﹤0.01% | 2216 |
|
|
2023
Q1 | $31.2M | Sell |
954,331
-721,445
| -43% | -$23.6M | 0.01% | 1152 |
|
|
2022
Q4 | $92.3M | Buy |
1,675,776
+506,041
| +43% | +$27.9M | 0.03% | 737 |
|
|
2022
Q3 | $51.8M | Buy |
1,169,735
+909,677
| +350% | +$40.3M | 0.02% | 897 |
|
|
2022
Q2 | $12.7M | Buy |
260,058
+57,750
| +29% | +$2.82M | ﹤0.01% | 1675 |
|
|
2022
Q1 | $9.84M | Buy |
202,308
+91,947
| +83% | +$4.47M | ﹤0.01% | 1971 |
|
|
2021
Q4 | $4.71M | Buy |
110,361
+100,902
| +1,067% | +$4.3M | ﹤0.01% | 2424 |
|
|
2021
Q3 | $362K | Buy |
9,459
+1,911
| +25% | +$73.1K | ﹤0.01% | 3540 |
|
|
2021
Q2 | $213K | Buy |
+7,548
| New | +$213K | ﹤0.01% | 3739 |
|